Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

42.20
Delayed Data
As of Jul 21
 -0.10 / -0.24%
Today’s Change
17.25
Today|||52-Week Range
44.95
+67.13%
Year-to-Date

Today’s Trading

Previous close42.30
Today’s open42.65
Day’s range42.00 - 42.90
Volume424,282
Average volume (3 months)606,199
Market cap$2.1B
Dividend yield--
Data as of 3:59pm ET, 07/21/2017

Growth & Valuation

Earnings growth (last year)+528.57%
Earnings growth (this year)-41.76%
Earnings growth (next 5 years)+27.00%
Revenue growth (last year)+48.87%
P/E ratio22.6
Price/Sales6.07
Price/Book11.00

Competitors

 Today’s
change
Today’s
% change
LOXOLoxo Oncology Inc-0.85-1.15%
HZNPHorizon Pharma PLC-0.04-0.31%
FOLDAmicus Therapeutics ...-0.08-0.59%
AERIAerie Pharmaceutical...+1.45+2.57%
Data as of 4:00pm ET, 07/21/2017

Financials

Next reporting dateAugust 10, 2017
EPS forecast (this quarter)$0.25
Annual revenue (last year)$215.0M
Annual profit (last year)$91.2M
Net profit margin42.43%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, Secretary &
Director
Jack A. Khattar
CFO, Vice President &
Head-Investor Relations
Gregory S. Patrick
Corporate headquarters
Rockville, Maryland

Forecasts